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Background: Hibernomas are rare benign soft-tissue tumours arising from brown fat tissue. Although imaging
characteristics are not specific certain imaging features, common locations and patient demographics may suggest
hibernoma as a differential diagnosis.
Case presentation: We report on two 48-year-old male patients with hibernoma. The tumour presented with local
swelling of the inguinal region in the first patient and was an incidental imaging finding in the second patient. Imaging
included magnetic resonance imaging in both patients and computed tomography as well as 18 F-fluorodeoxyglucose
positron emission tomography-computed tomography in the second patient. In both cases histological diagnosis was
initially based on excisional and needle core biopsy, respectively. Complete surgical resection confirmed the diagnosis
of hibernoma thereafter.
Conclusion: In soft tissue tumours with fatty components hibernoma may be included into the differential diagnosis.
Because of the risk of sampling errors in hibernoma-like tissue components of myxoid and well-differentiated liposarcoma,
complete resection is mandatory. This article also reviews the current imaging literature of hibernomas.
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Hibernomas are rare benign soft-tissue tumours arising
from brown fat tissue [1-3]. The tumour was first de-
scribed in 1906 by Merkel who named them “pseudoli-
poma” [4]. The name hibernoma was given by Gery in
1914 because of its similarity to brown fat in hibernating
animals [5]. Hibernomas count for approximately 1.6%
of all benign lipomatous tumours [6]. Until now, case re-
ports and series with up to 170 patients were published
[7]. Males are more often involved than females [7]. The
typical age at presentation is between 30 and 50 years.
Hibernomas are slowly growing, painless tumours, either
presenting as palpable soft and mobile mass or as an
incidental finding at imaging [3]. Due to the hyper-
vascularity, hibernomas may sometimes appear with lo-
cally increased skin temperature. They can reach a size
of up to 20 cm so that symptoms secondary to compres-
sion of adjacent structures may developed [7].* Correspondence: Dirk.Daubner@uniklinikum-dresden.de
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unless otherwise stated.The aetiology of hibernomas is unknown. Molecular
genetics show deletions respectively reciprocal translocation
of chromosome 11 which encodes the tumour suppressor
gene MEN 1 [8,9]. The development of hibernomas was
initially thought to be related to areas of residual brown fat
such as the interscapular area, axilla, chest wall, mediasti-
num or retroperitoneum. However, single case reports and
a clinical-pathological study with 170 cases showed the
thigh to be a preferential location with about 30% of the
cases [7].
At histopathology, most hibernomas present as typical
variant (82%) of which three cellular subtypes are differ-
entiated (pale staining, mixed and eosinophilic cells).
Myxoid variants (9%), lipoma-like variants (7%), and spin-
dle cell variants (2%) of hibernoma are less common [3,7].
Except intrathoracic and retroperitoneal hibernomas,
the tumours are usually well diagnosed with ultrasound
showing smooth borders and hyperechoic signal. Colour
duplex sonography and angiography often present a
hypervascular tumour, with arteriovenous shunts in
some cases. Due to the increased risk of bleeding, biopsy
is not recommended in these cases. But often the diagnosis
is not considered prior to biopsy in different imagingal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[3,10,11].
In computed tomography (CT) and magnetic resonance
imaging (MRI), hibernomas are well-circumscribed tu-
mours, commonly located in subcutaneous tissue, skeletal
muscle or intermuscular fascial planes. Common sites in-
clude thigh, peri- and interscapular region, axilla, neck,
chest, abdominal cavity and retroperitoneum. The scalp,
breast, scrotum and perirectal region, spine and bones are
less frequently affected [3,7,12]. Hibernomas show rela-
tively low attenuation in CT between the attenuation of
subcutaneous fat and skeletal muscle. Intratumoural septa
and a variable degree of enhancement may be seen
[1,13,14]. In MRI, hibernomas may be slightly hypointense
to fatty tissue on T1- and T2-weighted images and mark-
edly hyperintense when fat suppressed T2-weighted inver-
sion recovery sequences are applied. Elongated and
branching vessels within the tumour are typically seen as
flow void phenomena in MRI. Nevertheless, lack of intra-
tumoural vessels does not exclude hibernoma [2,3,10].
After intravenous contrast agent administration strong en-
hancement of intratumoural blood vessels and homoge-
neous or heterogeneous tumour enhancement may be
observed [10]. In 18 F-fluorodeoxyglucose (FDG) positron
emission tomography-computed tomography (PET/CT)
high uptake is measured in hibernomas due to the meta-
bolic activity of brown fat. Therefore, differentiation from
malignant tumours is difficult [3,10,15,16]. Compared to
liposarcomas, hibernomas often show higher standardized
uptake values (SUVs) and change of FDG avidity in
follow-up. However, these criteria are not reliable enough
to make the diagnosis based on imaging alone [16,17].Figure 1 48-year-old man with hibernoma of the left upper leg. Tumo
a-d). MRI shows an isointense tumour compared to fat with slight rim enhan
a plain T1-weighted-TSE (TR 819 ms/ TE 11 ms), b plain T2-weighted-TSE (TR 5
(TR 895 ms/ TE 11 ms), d contrast enhanced fat saturated T1-weighted-TSE (TRHibernomas are benign tumours without a risk of ma-
lignant transformation or metastases [7,18]. As soon as
the diagnosis is confirmed, no surgical removal or other
treatment is required in asymptomatic hibernoma [16].
However, histological features similar to hibernomas are
described in atypical fatty tumours as well as in myxoid
and well-differentiated liposarcomas. Consequently, bi-
opsy proven diagnosis of hibernoma does not exclude
hibernoma-like differentiation in myxoid or well-
differentiated liposarcomas and complete excision is
indicated. Incomplete resection of hibernoma carries
the risk of recurrence, whereas complete resection
cures the disease [7,19].
Case presentation
Case 1
A 48-year-old male patient was admitted to our hospital
with a palpable soft-tissue swelling at the left upper leg
extending to the groin. The tumour was slowly growing
since approximately 6 months. MRI was performed
(Siemens Magnetom Verio®, 3.0 Tesla, body-array-coil,
Erlangen, Germany) showing a 4 × 10 × 12 cm meas-
uring mass between the gluteus medius and minimus
muscles which was isointense to fat in all sequences.
The tumour extended from the greater trochanter of
the femur to the anterior superior iliac spine (Figure 1).
After intravenous administration of contrast medium
(15 ml Magnevist®, 0.5 mmol/ml, Bayer Vital GmbH,
Leverkusen, Germany) slight rim enhancement of the
tumour (arrow in Figure 1c) and a prominent vessel
within the tumour (arrow in Figure 1d) were seen.
Based on imaging findings, the working diagnosis wasur between the gluteus medius and minimus muscles (star in image 1
cement (arrow in c) and a prominent vessel within the mass (arrow in d).
050 ms/ TE 96 ms), c contrast enhanced fat saturated T1-weighted-TSE
680 ms/ TE 11 ms).
Figure 2 Tumour, composed of multivacuolated eosinophilic
(arrow) and pale cells (double arrow), dissecting between skeletal
muscle fibers (asterisk). H & E stain, original magnification 10x.
Figure 3 48-year-old man with right-sided retroperitoneal
hibernoma. Tumour between the psoas and iliac muscles (arrows).
Contrast enhanced CT shows minimal heterogeneous enhancement
of the tumour. a coronal reconstruction, b axial slice.
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ciplinary sarcoma board of our comprehensive cancer
center. As a result, diagnostic excision was suggested
which was performed without complications.
Histopathology of the specimen (2 × 1.2 × 1 cm) re-
vealed an intramuscular lipomatous neoplasia, complying
with the diagnosis of the pale cell subtype of typical hiber-
noma (Figure 2). In-toto excision of the encapsulated
hibernoma followed two weeks later. Histopathology con-
firmed the diagnosis of hibernoma and liposarcoma could
be excluded. Postsurgery MRI follow-up after one year
proved that no recurrence has occurred.Case 2
A 48-year-old male patient presented in our emergency
department with upper abdominal pain, elevated liver
enzymes and laboratory parameters of cholestasis. Acute
cholecystitis was suspected and abdominal ultrasound
was performed. Due to overlying bowel gas the gallblad-
der could not be examined completely. Consequently,
abdominal CT (Siemens Somatom Definition AS + ®, Er-
langen, Germany, collimation 2 × 64 × 0.6 mm, current
129 mA, tube voltage 120 kV) with both intravenous
(90 ml Solutrast® 300 mg I/ml, Bracco Imaging Deutschland
GmbH, Konstanz, Germany; imaging delay 65 sec.) and oral
contrast administration (1000 ml H20 + 30 ml Gastrolux®
370 mg I/ml, Sanochemia Diagnostics Deutschland GmbH,
Neuss, Germany) was performed to exclude gallbladder
perforation. CT showed increased enhancement of the gall-
bladder wall and pericholecystitic infiltration of fatty tissue
compatible with acalculous cholecystitis. There was no dila-
tation or wall thickening of the intra- or extrahepatic bileducts. Endosonography was performed thereafter, showing
a single stone in the middle part of the common bile
duct, which was treated with endoscopic retrograde
cholangiopancreatography.
CT incidentally revealed a 5.5 × 1.5 × 5.5 cm measur-
ing retroperitoneal tumour located between the right
psoas and iliac muscles (Figure 3). The tumour showed
mean density values between 10–15 Hounsfield Units
(HU). For further diagnostic work-up MRI of the abdomen
was performed (Siemens Magnetom Verio®, 3.0 Tesla,
body-array-coil, Erlangen, Germany). Turbo inversion re-
covery magnitude (TIRM) sequences revealed a hype-
rintense tumour that was slightly hypointense in T1- and
T2-weighted sequences compared to mesenteric fat. After
administration of intravenous contrast agent (15 ml
Magnevist®, 0,5 mmol/ml, Bayer Vital GmbH, Leverkusen,
Germany) there was a strong heterogeneous enhancement.
Based on CT and MRI the working diagnosis was a poten-
tially malignant mesenchymal tumour (Figure 4). Therefore,
PET/CT (Siemens Biograph 16®, Knoxville, USA, collima-
tion 16 × 1.5 mm, tube currency 9/97 mAs, tube voltage
100/120 kV) with 18 F-FDG (5 MBq/kg body weight) was
performed which showed an increased accumulation of 18
F-FDG (SUVmax 12.3) within the tumour 60 minutes after
injection. 18 F-FDG-PET/CT further supported the working
diagnosis of a malignant tumour (Figure 5).
Histological examination was performed after CT-
guided biopsy of the soft-tissue lesion (Quick Core Bi-
opsy Needle Sets QCS-18-15-20 T, Cook Medical Inc.,
Bloomington, USA). Histological analysis yielded the
pale cell subtype of a typical hibernoma (Figure 6). After
discussion in the multidisciplinary sarcoma board of the
comprehensive cancer center at our hospital elective
tumour excision was performed 2 months after biopsy.
The final histological diagnosis of the surgical specimen
confirmed the presumptive diagnosis of the biopsy.
Conclusion
Hibernomas are benign, well-circumscribed, slowly grow-
ing and well vascularised soft-tissue tumours containing
Figure 4 MRI of the same patient as shown in Figure 3. The tumour (arrows) is slightly hypointense compared to mesenteric fat in T2- (a, TSE, TR
5040 ms/ TE 137 ms) and T1-weighted images (b, TSE, TR 651 ms/ TE 11 ms). The T2-weighted TIRM sequence (c) shows marked hyperintensity of the
mass (c, TR 5000 ms/ TE 74 ms/ TI 170 ms). After administration of contrast medium heterogeneous enhancement occurs (d, fat saturated TSE, TR 600
ms/ TE 11 ms).
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imaging findings suggestive of hibernoma. These findings
include hypointensity to fatty tissue on T2-weighted im-
ages and hyperintense signal intensity on TIRM images.
Large intratumoural blood vessels, heterogeneous contrast
enhancement and strong FDG uptake are further imaging
signs [2,3,10,15,16].
The differential diagnosis of lipomatous soft-tissue tu-
mours is broad and comprises benign (e. g. lipoma,
hemangioma, angiolipoma) and malignant (e. g. liposar-
coma) lesions [1,14,20]. Lipomas are characterized by
homogeneous adipose tissue which can show thin septa.
There is no contrast enhancement within lipomas, al-
though infections, infarctions and necrosis as well as
muscle fibres, intratumoural vessels und fibrotic septa
may hamper the diagnosis [21]. Dependent on fat content,Figure 5 18 F-FDG-PET/CT of the same patient as shown in
Figure 3 and 4 demonstrates increased FDG-activity of the
mass (arrows). CT was performed in low-dose technique (9/97 mAs,
100/120 kV). a coronal reconstruction, b axial slice.haemangiomas and angiolipomas show hypo- to hyperin-
tense signal on T1-weighted images and hyperintense signal
on T2-weighted images with intrinsic vessels. Haemangi-
omas can also contain calcifications similar to phlebolits
[10]. Imaging characteristics of liposarcomas depends on
the histological differentiation. Well-differentiated liposar-
comas have thickened septa (>2 mm) as well as areas of
T2-hyperintensity. Enhancement can be absent or circum-
scribed [10,20,21]. The signal intensity on T1-weighted im-
ages is often similar to subcutaneous fat. Moreover, largeFigure 6 Surgical specimen of hibernoma with univacuolar
white fat cells (arrow). H & E stain, original magnification 15× .
Table 1 Summary table of hibernomas
Aetiology Unclear, deletion respectively reciprocal translocation of chromosome 11
Incidence Approximately 1.6% of all benign lipomatous tumours
Gender distribution Slight male predominance
Average age 3rd to 4th decade of life
Risk factors Not known
Therapy Complete excision of symptomatic hibernoma or unclear diagnosis
Prognosis Benign tumour without malignant transformation or metastatic spread
No recurrence after complete excision, possible recurrence in cases of incomplete excision
Imaging characteristics Well-defined, richly vascularized soft tissue tumour with a density between subcutaneous fat and skeletal muscle in CT,
respectively slightly hypointense to subcutaneous fat in T1w and T2w MR images, hyperintense in TIRM, heterogenous to
homogenous enhancement, high 18 F-FDG uptake and change of FDG avidity in follow-up
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from hibernomas. Poorly differentiated liposarcomas are
rarely confounded with hibernomas due to the low fat
content [20,21].
However, despite the use of multimodal imaging, the
radiologic diagnosis of hibernomas is difficult and differ-
entiation from well-differentiated liposarcomas remains
a challenge even after biopsy. Therefore, complete surgi-
cal resection is highly recommended. A summary table
of hibernomas is shown in Table 1.
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